Saturday 17 October 2026
Export PRE’s income statement to Excel — free account
Prenetics Global Limited
PRE Consumer Defensive Packaged Foods
Prenetics Global Limited’s revenue for fiscal 2025 (year ended December 2025) was $92.4 million, up 479.8% from fiscal 2024. In the quarter to June 2026, revenue grew 288.6%, EPS grew 44.7% and free cash flow fell 297.2%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
18.52
1.74
−8.59%
Follow PRE
| Dec '17 | Jan '21 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 5 | 4 | 5 |
P/E ratio |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 0.77 | (0.45) | (2.02) | — | — |
P/S ratio |
— | — | 0.00 | 10.69 | 2.91 | 4.55 | 2.40 |
Altman Z″-Score (non-manufacturers) |
— | — | (0.47) | 1.92 | (1.00) | — | — |
P/FCF ratio |
— | — | 0.00 | 9.90 | 121.87 | 0.00 | 0.00 |
P/Operating CF |
— | — | (40,132.02) | 9.69 | (4.59) | (2.51) | (10.14) |
Beneish M-Score |
— | — | — | 1.22 | (2.68) | (2.47) | 0.84 |
P/B ratio |
— | — | 0.00 | 0.58 | 0.30 | 0.42 | 1.42 |
Price to Tangible BV |
— | — | 0.00 | 0.72 | 0.38 | 0.59 | 2.01 |
EV/Sales |
— | — | 0.00 | (1.27) | 0.49 | 1.85 | 2.15 |
EV/EBITDA |
— | — | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | 0.00 | (1.18) | 20.63 | (1.04) | (3.31) |
EV/FCF |
— | — | 0.00 | (1.18) | 20.63 | (1.04) | (1.46) |
Quick Ratio |
— | 0.03 | 14.38 | 3.64 | 1.67 | 1.57 | 1.22 |
Current Ratio |
— | 0.19 | 0.19 | 4.23 | 2.37 | 2.36 | 2.97 |
Net Debt/EBITDA |
— | 0.03 | 0.03 | 2.85 | 1.40 | 1.72 | 0.79 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.81 | 0.04 | 0.08 | 0.07 | 0.44 |
Operating CF/Net income |
— | 0.42 | 1.41 | (0.08) | 0.22 | 0.62 | 0.58 |
Capex/Depreciation |
— | — | 0.00 | (0.83) | (0.10) | (0.17) | (14.43) |
| — | (1.06%) | (0.68%) | (176.01%) | (27.65%) | (24.27%) | (23.01%) | |
| — | (1.94%) | (0.29%) | (58.39%) | (22.15%) | (19.80%) | (17.97%) | |
ROIC |
— | 0.00% | 0.00% | (53.67%) | (21.85%) | (19.03%) | (22.38%) |
Return on Tangible Assets |
— | 123.97% | (9.36%) | (96.33%) | (104.62%) | (80.66%) | (64.74%) |
Average Days of Receivables |
— | — | 62.26 | 1,156.01 | 70.42 | 120.13 | 11.78 |
Research and Development Expense of Revenue |
— | — | 3.83% | 45.50% | 53.64% | 56.80% | 5.55% |
Selling, General and Administrative Expense of Revenue |
— | — | 38.40% | 486.79% | 228.49% | 241.61% | 88.69% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.08 | 0.16 | 0.17 | 0.23 | 0.22 |
Share Based Compensation of Revenue |
— | — | 0.00% | 920.15% | 48.70% | 75.16% | 8.23% |
Graham Net Nets |
— | — | (0.09) | 1.23 | 0.79 | 0.61 | 0.16 |
Graham Number |
— | — | 24.79 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | (38.48%) | (225.13%) | (85.38%) | (65.60%) | (25.52%) |
Free Cash Flow Yield |
— | — | 0.00% | 10.10% | 0.82% | (38.95%) | (61.60%) |
Revenue per Share |
— | 0.00 | 430.89 | 2.60 | 1.93 | 1.28 | 6.57 |
Operating CF per Share |
— | (0.03) | (2.14) | 2.86 | (1.22) | (2.31) | (1.55) |
Capex per Share |
— | 0.00 | 0.00 | (1.24) | (0.07) | (0.08) | (3.88) |
Free Cash Flow per Share |
— | (0.03) | (2.14) | 1.62 | (1.30) | (2.39) | (5.44) |
Cash per Share |
— | 0.00 | 0.16 | 32.86 | 5.49 | 4.18 | 2.29 |
Shareholders Equity per Share |
— | 7.11 | (42.26) | 48.03 | 18.69 | 13.71 | 11.13 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 7.11 | (42.26) | 48.03 | 18.69 | 13.71 | 11.13 |
Free Cash Flow |
— | (1.37) | (1.37) | 8.22 | (14.58) | (29.90) | (76.38) |
Working Capital |
— | (2.67) | (2.67) | 184.62 | 54.18 | 49.60 | 56.48 |
Capital Expenditures |
— | — | (11.41) | (6.29) | (0.81) | (1.02) | (54.55) |
Net Current Asset Value |
— | (27.28) | (366.62) | 173.14 | 49.65 | 43.92 | 35.49 |
EV/EBIT |
— | — | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | 0.00 | 0.48 | 0.04 | 0.06 | 0.59 |
Price to Operating Income |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||
Depreciation/Fixed assets |
— | — | 0.56 | 0.58 | 1.35 | 0.76 | 2.14 |
Cash ROIC |
— | (0.44%) | 5.09% | 2.01% | (5.36%) | (13.37%) | (40.52%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.30 | 0.95 | 3.38 | 22.46 |
Accounts Payable Turnover |
— | — | 0.00 | 2.52 | 2.88 | 2.49 | 12.80 |
Inventory Turnover |
— | — | 0.00 | 1.68 | 3.37 | 1.37 | 6.41 |
Average Days of Payables |
— | — | 0.59 | 278.80 | 47.23 | 201.05 | 26.30 |
Days of Inventory on Hand |
— | — | 14.69 | 173.37 | 88.39 | 359.90 | 58.87 |
Average Receivables |
— | — | — | 44.37 | 22.94 | 4.72 | 4.11 |
Average Payables |
— | — | — | 3.78 | 4.48 | 2.67 | 3.41 |
Average Inventory |
— | — | — | 5.68 | 3.83 | 4.85 | 6.80 |
Average Assets |
— | 170.09 | 340.18 | 326.15 | 283.15 | 233.87 | 209.82 |
Average Common Equity |
— | 312.29 | 142.62 | 108.20 | 226.81 | 190.75 | 163.86 |
Columns are period end dates